AviadoBio Ltd. ("AviadoBio") and Apertura Gene Therapy ("Apertura"), a biotechnology company developing next-generation AAV capsids for delivering genetic medicines, today announced a licensing ...
Tessera Therapeutics (“Tessera”), the biotechnology company pioneering a new approach in genetic medicine known as Gene Writing™, today announced four presentations of new preclinical data at the ...
Oral presentation highlights novel compact RT editor demonstrating first preclinical in vivo proof of concept for precise ...
Tessera Therapeutics (“Tessera”), the biotechnology company pioneering a new approach in genetic medicine known as Gene W ...
The treatment, the first of its kind, was approved by the Food and Drug Administration on Thursday. “Our baby was born deaf, ...
Intellia Therapeutics Inc. said its gene-editing treatment for a rare swelling disorder met its goal in a late-stage trial, ...
Ocugen OCGN is pushing a modifier gene therapy platform across several retinal diseases where current options are limited, ...
Humanity is gradually conquering incurable genetic diseases that were once considered untreatable, thanks to a series of ...
Late-stage trial shows Intellia's one-time gene-editing therapy lonvoguran ziclumeran cut hereditary angioedema swelling ...
3don MSN
Re-engineered human cells boost gene-editing particle potency across multiple delivery systems
Gene editing has emerged as a powerful approach for targeting the genetic causes of disease, but getting the editing ...
Scientists in Shanghai have identified a "brake" gene that could potentially halt the progression of Alzheimer's disease, ...
Genome editing is revolutionizing the medical landscape by offering new therapeutic possibilities for genetic diseases, which collectively affect hundreds ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results